The Ligand-binding Domain of CD22 Is Needed for Inhibition of the B Cell Receptor Signal, as Demonstrated by a Novel Human CD22-specific Inhibitor Compound

por Kelm, Soerge, Gerlach, Judith, Brossmer, Reinhard, Danzer, Claus-Peter, Nitschke, Lars
Publicado 2002